Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Apyx Medical Corporation Submits FDA 510(k) for Device Label Expansion of AYON Body Contouring System™ for Power Liposuction
-
TurnOnGreen Teams Up with Kinseth Hospitality to Expand EV Charging Across the Portfolio
-
SELLAS Life Sciences to Present In Vivo Preclinical Data Demonstrating Statistically Significant Survival Benefit of SLS009 in T-Cell Prolymphocytic Leukemia at the European Society for Medical Oncolo
-
Enphase Energy Expands Virtual Power Plant Support Across Europe
-
Soleno Therapeutics Appoints Biopharmaceutical Executive Mark W. Hahn to its Board of Directors
-
Connect Appoints Tre Braquet as Chief Brand & Engagement Officer
-
Excellergy Debuts with $70 Million Series A Financing to Advance First-in-Class Portfolio of Trifunctional Effector Cell Response Inhibitors (ECRIs) for Complete Allergic Control
-
Theriva™ Biologics Announces Upcoming Presentations at Medical Meetings
-
LGI Homes Announces Rivenwick Village: A New Community Offering Townhome Living in Ramsey, MN
-
Hinge Bio Announces FDA Clearance of Investigational New Drug Application for HB2198, a Novel B cell-Depleting Agent, for Patients with Systemic Lupus Erythematosus and Lupus Nephritis
-
STMicroelectronics announces status of common share repurchase program
-
MKS Inc. Announces Third Quarter 2025 Earnings Conference Call
-
HonorHealth Named Title Sponsor for Arizona High School Pickleball Championships Dec. 6 & 7, 2025
-
Cidara Therapeutics to Present Late-Breaking Clinical Phase 2 Data on CD388 at ID Week 2025
-
Big Sky Medical Expands North Texas Presence with the Acquisition of Hillcrest Medical Park in Frisco
-
Compliance & Risks Launches AI Sustainability Platform
-
House of Doge, the Corporate Arm of the Dogecoin Foundation, to List on NASDAQ Through Merger with Brag House Holdings, Inc.
-
Aeries Technology’s Nearshore Model Delivers Over $20 Million in Client Savings
-
Ethereum-Based Mutuum Finance (MUTM) Records 62% Phase 6 Completion and $17.2M in Funding
-
MicroCloud Hologram Inc. Researches a Full-Cycle Feasible Path for Achieving Quantum Computing Advantage in the Short Term
-
Gabelli and Columbia Business School to Host 7th Annual Healthcare Symposium
-
Abacus Global Management Announces Upcoming Conference Participation
-
Brookfield to Acquire Remaining Interest in Oaktree
-
Immutep Announces Successful Completion of FDA Project Optimus Requirements
-
Nuvini Announces Open-Market Stock Purchases by Key Executives
-
Discuss Recognized by OpenAI for 10B+ Tokens Milestone, Cementing Market Leadership
-
4DMT Advances 4D-710 to Phase 2 with Additional Funding and Support from the Cystic Fibrosis Foundation
-
Bringing Halloween Magic to Life for Children with Autism Spectrum Disorder and Sensory Sensitivities
-
Collegium to Celebrate 10-Year Anniversary with Nasdaq Opening Bell Ringing
-
Rapala VMC Corporation’s Financial Reporting in 2026
-
STMicroelectronics announces status of common share repurchase program
-
HMNC Brain Health Presents New Analysis Supporting Rationale for Combining a Genetic Patient Selection Tool with a Vasopressin V1b Receptor Antagonist in the Treatment of Depression at ISCTM Conferenc
-
Kymeta Selected as Multi-Orbit SATCOM Provider for U.S. Army’s NGC2 Pilot
-
Michelin | Disclosure of the total number of voting rights and of the number of shares making up the Company’s capital
-
Richard Johnson Resignation and New Appointment
-
Share buy-back program
-
Stereotaxis & CardioFocus Collaborate to Advance Robotic Pulsed Field Ablation for Cardiac Arrhythmias
-
Bicara Therapeutics Announces Ficerafusp Alfa Granted Breakthrough Therapy Designation by U.S. FDA for 1L HPV-Negative R/M HNSCC
-
Auction result of Treasury Bills - RIKV 26 0121 - RIKV 26 0415
-
Compass Lexecon Adds Antitrust and Finance Expertise with Two Senior Hires
-
U.S. Food and Drug Administration Awards Year Two Proceeds from Orphan Products Grant Supporting Palvella Therapeutics’ Phase 3 SELVA Trial of QTORIN™ Rapamycin for Microcystic Lymphatic Malformat
-
Blaqclouds Partners with ApeGames to Revolutionize Crypto Payments During ApeFest Vegas 2025
-
Watsco Schedules Third Quarter Earnings Call on October 29, 2025
-
AYR Wellness Announces Commencement of Restructuring Support Agreement Article 9 Proceedings
-
Verifone Launches Commander Fleet to Simplify Fleet Card Processing
-
SemiCab Appoints New VP of US Sales for its AI Logistics Software
-
Abeona Therapeutics® Announces ABO-503 Gene Therapy for X-linked Retinoschisis (XLRS) Selected by FDA for Rare Disease Endpoint Advancement (RDEA) Pilot Program
-
Stardust Power Strengthens Construction Team with Ken Pitts
-
BriaCell to Present Positive Clinical Biomarker Data of Phase 3 Study at ESMO 2025
-
Dragonfly Energy Announces Third Quarter 2025 Select Preliminary Results
